Keith R. McCrae

Director. Benign Hematology, Taussig Cancer Institute
Cleveland Clinic Foundation, Cleveland, OH, USA
Clevelend, Ohio, United States

Presentation(s):

• PB0934 - The Safety and Efficacy of Direct Oral Anticoagulants (DOACs) Versus Low Molecular Weight Heparin (LMWH) in the Treatment of Thromboembolism (TE) in Patients with Hematological Malignancies

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB0963 - Clinical Outcomes of Anticoagulation for The Treatment of Thromboembolism (TE) in Elderly Cancer Patients

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB1458 - Thromboembolic (TE) Events in Cold Agglutinin Disease (CAD): Post-hoc Analysis PRE- and ON-sutimlimab Treatment in the Phase 3 CARDINAL and CADENZA Studies

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• OC 70.1 - High molecular kininogen cleavage in cerebral malaria

  Wednesday, June 28, 2023
  10:15 – 10:30 ET